Abstracts tagged "Biologics and cost containment"

Abstract Number: 1160 • 2014 ACR/ARHP Annual Meeting
Annual Real-Practice Costs of Biologics for 200 Cases with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Treated By Tight Control and Treat to Target Strategy Permitting Dose Reduction
Bernd Raffeiner¹, Costantino Botsios², Michele Ragazzi³ and Ernesto De Menis⁴, ¹Department of Medicine, Rheumatology - General Hospital Bolzano, Bolzano, Italy, ²Department of Medicine, Rheumatology - Hospital San Valentino Montebelluna, Montebelluna, Italy, ³Pharmacy - Hospital San Valentino Montebelluna, Montebelluna, Italy, ⁴Department of Medicine, Internal Medicine - Hospital San Valentino Montebelluna, Montebelluna, Italy
Background/Purpose To investigate annually real-practice costs of biologic therapy for rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) cohort treated by tight control…